Published in Am J Med on April 01, 1999
Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A (2004) 4.89
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development. Am J Respir Crit Care Med (2016) 1.47
Effects of quitting cannabis on respiratory symptoms. Eur Respir J (2015) 1.42
Genome-wide association study of smoking behaviours in patients with COPD. Thorax (2011) 1.18
Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res (2007) 1.13
Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med (2010) 1.11
The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med (2009) 1.08
Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years. Chest (2010) 1.05
Smoking prevalence and smoking cessation services for pregnant women in Scotland. Subst Abuse Treat Prev Policy (2010) 1.03
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PLoS One (2010) 0.92
A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol. Implement Sci (2012) 0.91
Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax (2001) 0.89
Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet (2012) 0.88
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health (2009) 0.88
Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.87
Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review. Tob Control (2007) 0.87
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.83
Cough in chronic obstructive pulmonary disease: is it important and what are the effects of treatment? Cough (2013) 0.83
Adenosine receptors in COPD and asymptomatic smokers: effects of smoking cessation. Virchows Arch (2009) 0.82
Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010. Chest (2012) 0.82
On multi-marker tests for association in case-control studies. Front Genet (2013) 0.81
Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med (2012) 0.80
Supporting smoking cessation in chronic obstructive pulmonary disease with behavioral intervention: a randomized controlled trial. BMC Fam Pract (2013) 0.80
The Korean Cough Guideline: Recommendation and Summary Statement. Tuberc Respir Dis (Seoul) (2015) 0.79
Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res (2016) 0.79
Integrated management strategies for chronic obstructive pulmonary disease. J Multidiscip Healthc (2010) 0.78
Copd. BMJ Clin Evid (2011) 0.77
Treatment of mild chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 0.77
Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial. PLoS One (2015) 0.76
Smoking cessation strategies for patients with asthma: improving patient outcomes. J Asthma Allergy (2016) 0.76
Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. Int J Chron Obstruct Pulmon Dis (2009) 0.75
Copd. BMJ Clin Evid (2008) 0.75
Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Prevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: Cross-sectional studies. PLoS One (2017) 0.75
Chronic Bronchitis in Chronic Obstructive Pulmonary Disease. Magnifying Why Smoking Cessation Still Matters Most. Ann Am Thorac Soc (2016) 0.75
Texture-based Quantification of Centrilobular Emphysema and Centrilobular Nodularity in Longitudinal CT Scans of Current and Former Smokers. Acad Radiol (2016) 0.75
A pilot randomized controlled trial of smoking cessation in an outpatient respirology clinic. Can Respir J (2015) 0.75
Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respir Res (2016) 0.75
Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med (2016) 0.75
Extending the case-control design to longitudinal data: stratied sampling based on repeated binary outcomes. Epidemiology (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med (1994) 8.97
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am J Public Health (1993) 3.38
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell (1990) 2.95
A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol (1994) 2.87
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
The one-year surgical outcome after prism adaptation for the management of acquired esotropia. Ophthalmology (1996) 2.76
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science (1992) 2.40
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest (1994) 2.29
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
Bronchodilator response in the lung health study over 11 yrs. Eur Respir J (2005) 2.26
Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med (2000) 2.21
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol (1998) 2.10
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Hematologic effects of flt3 ligand in vivo in mice. Blood (1996) 2.02
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc (1984) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol (1995) 1.86
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
A test of crystal structure prediction of small organic molecules. Acta Crystallogr B (2000) 1.84
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol (1996) 1.82
The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor. Mol Cell Biol (1991) 1.76
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71
Preventing deaths from asthma. N Engl J Med (1994) 1.70
Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc (1995) 1.70
Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature (1991) 1.67
Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (1991) 1.66
Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab (1975) 1.64
Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60
Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J (1991) 1.58
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55
Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53
The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis (1992) 1.53
Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52
Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med (1993) 1.52
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51
c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell (1992) 1.50
Long-term psychologic implications of congenital heart disease: a 25-year follow-up. Mayo Clin Proc (1991) 1.49
Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49
Perfluorocarbon priming and surfactant: physiologic and pathologic effects. Crit Care Med (1999) 1.48
Fish models for environmental carcinogenesis: the rainbow trout. Environ Health Perspect (1996) 1.48
Chemical and biological evidence links microcystins to salmon 'netpen liver disease'. Toxicon (1993) 1.46
Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest (1996) 1.45
A prospective psychological evaluation of patients with dysphagia of various etiologies. Dysphagia (1996) 1.44
Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42
COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41
Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg (1984) 1.41
20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40
Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40
Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40
Partial liquid ventilation: a comparison using conventional and high-frequency techniques in an animal model of acute respiratory failure. Crit Care Med (1997) 1.40
Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood (1994) 1.37
Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J (1991) 1.37
Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36
Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood (1991) 1.35
Pulmonary function studies in healthy Pakistani adults. Thorax (1978) 1.34
Echocardiographic detection of large left to right shunts and cardiomyopathies in infants and children. Am J Cardiol (1976) 1.34
Self-injurious behavior: a state-wide prevalence survey of the extent and circumstances. Appl Res Ment Retard (1986) 1.34